General Information
Version
1.2
Revision date
2023-08-11
Product name
Sedivet solution for injection
Product Synonyms
Sedivet® solution for injection 1.0%, Romifidine hydrochloride 0.2g/20ml Solution for Injection, Sedivet™ 1.0% Injection (ro- mifidine hydrochloride), Sedivet® 10 mg/mL solution for injec- tion for horses with active ingredient: Romifidine hydrochloride
1.2.1 Relevant identified uses
Veterinary product
1.2.2. Uses advised against
Safety Data Sheet only for the professional user., For veteri- nary use only, Refer to the product insert for complete instruc- tions on usage
supplier name
Boehringer Ingelheim AH USA
Emergency telephone
+1 703-527-3887, +1 703-741-5970
Icons in SDS
Company Information
company name
Boehringer Ingelheim AH USA
e-mail address of the competent person responsible for the Safety Data Sheet
EHS-Services@Boehringer-Ingelheim.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H370
Hazard statements
Code
Statements
H370
Causes damage to organs
Section 2
SECTION 2: Hazards identification
Signal word
Danger
Hazard statements
H370 Causes damage to organs (Cardio-vascular system, Cen- tral nervous system).
Prevention
P260 Do not breathe mist or vapours. P264 Wash skin thoroughly after handling. P270 Do not eat, drink or smoke when using this product.
Response
P307 + P311 IF exposed: Call a POISON CENTER or doctor/ physician.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
2.3 Other hazards
This drug is not subject to the labelling requirements under the Globally Harmonized System (GHS) The pharmacological effect of the medicament has to be considered (see package leaflet).
2.1 Classification of the substance or mixture
1910.1200) Specific target organ toxicity : Category 1 (Cardio-vascular system, Central nervous system) - single exposure
